Emerging Diseases and Outbreaks

Emerging Diseases and Outbreaks

Global

track_changes Track Tracking Be alerted when new articles are added in this gateway (manage your tracking alerts via your account) Stop tracking this gateway
121-140 of 176 ARTICLES
https://doi.org/10.12688/f1000research.28393.1
Systematic Review metrics
Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis
[version 1; peer review: 2 approved, 1 approved with reservations]
Peer Reviewers Cissy B. Kartasasmita; Seyi Samson Enitan; Mahir Gachabayov
PUBLISHED 21 Jan 2021
https://doi.org/10.12688/f1000research.42308.1
Systematic Review metrics
Hemorrhagic and ischemic stroke in patients with coronavirus disease 2019: incidence, risk factors, and pathogenesis - a systematic review and meta-analysis
[version 1; peer review: 3 approved]
Peer Reviewers Ismail Setyopranoto; Guilherme Welter Wendt; Mahir Gachabayov
PUBLISHED 19 Jan 2021
https://doi.org/10.12688/f1000research.26482.2
Opinion Article metrics
Revised
Option-based guarantees to accelerate urgent, high-risk vaccines: a new market-shaping approach
[version 2; peer review: 2 approved]
Peer Reviewers Daniel L. Tortorice; Rino Rappuoli and Simone Pecetta
LATEST VERSION PUBLISHED 11 Jan 2021
https://doi.org/10.12688/f1000research.27287.2
Brief Report metrics
Revised
‘The long tail of Covid-19’ - The detection of a prolonged inflammatory response after a SARS-CoV-2 infection in asymptomatic and mildly affected patients
[version 2; peer review: 2 approved]
Peer Reviewers William J. griffiths; Paul Skipp
  • Funders
  • Great Ormond Street Institute of Child Health
  • National Institute for Health Research
  • University College London
LATEST VERSION PUBLISHED 08 Jan 2021
https://doi.org/10.12688/f1000research.22149.4
Brief Report metrics
Update
Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural reservoir, tropism and therapeutic/vaccine target
[version 4; peer review: 2 approved]
Peer Reviewers Rita Casadio; Maria Salvato
LATEST VERSION PUBLISHED 06 Jan 2021
https://doi.org/10.12688/f1000research.26186.2
Systematic Review metrics
Revised
Predictors of COVID-19 severity: a systematic review and meta-analysis
[version 2; peer review: 2 approved]
Peer Reviewers Morteza Arab-Zozani; Annelies Wilder-Smith
  • Funder
  • Lembaga Pengelola Dana Pendidikan
LATEST VERSION PUBLISHED 06 Jan 2021
https://doi.org/10.12688/f1000research.25842.2
Opinion Article metrics
Revised
Effects of rapid recruitment and dissemination on Covid-19 mortality: the RECOVERY trial
[version 2; peer review: 2 approved]
Peer Reviewers Carlos J. Chaccour; Heidi R. Gardner
LATEST VERSION PUBLISHED 23 Dec 2020
https://doi.org/10.12688/f1000research.23829.2
Research Article metrics
Revised
Computational screening for potential drug candidates against the SARS-CoV-2 main protease
[version 2; peer review: 2 approved]
Peer Reviewers Murtaza Tambuwala; Alaa A A Aljabali
  • Funder
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
LATEST VERSION PUBLISHED 21 Dec 2020
https://doi.org/10.12688/f1000research.27681.1
Brief Report metrics
Phylogenetic analysis of the betacoronavirus S1 subunit
[version 1; peer review: 1 approved with reservations, 1 not approved]
Peer Reviewers Houcemeddine Othman; Peng Zhou
  • Funder
  • The Ministry of Science and Higher Education of the Russian Federation
PUBLISHED 03 Dec 2020
https://doi.org/10.12688/f1000research.26253.2
Opinion Article metrics
Revised
Adaptive platform trials using multi-arm, multi-stage protocols: getting fast answers in pandemic settings
[version 2; peer review: 2 approved]
Peer Reviewers Cyrus Mehta; Dmitri Nepogodiev
  • Funder
  • Medical Research Council
LATEST VERSION PUBLISHED 23 Nov 2020
https://doi.org/10.12688/f1000research.25836.1
Brief Report metrics
Dried blood spots are an efficient blood sampling method for the detection of SARS-CoV-2 antibodies
[version 1; peer review: 2 not approved]
Peer Reviewers Livia Melo Villar; Davor Brinc
PUBLISHED 20 Nov 2020
https://doi.org/10.12688/f1000research.26055.1
Brief Report metrics
Lethality model for COVID-19 based on social determinants of health: an approximation in 67 countries
[version 1; peer review: 1 approved, 1 approved with reservations]
Peer Reviewers Ahmed M. Abbas; Hector Florez
PUBLISHED 30 Oct 2020
https://doi.org/10.12688/f1000research.24751.2
Software Tool Article metrics
Revised
Reproducibly sampling SARS-CoV-2 genomes across time, geography, and viral diversity
[version 2; peer review: 2 approved]
Peer Reviewers James Hadfield; C. Titus Brown
  • Funders
  • Arizona Board of Regents
  • Alfred P Sloan Foundation
  • National Cancer Institute
  • Australian National University
  • National Science Foundation
  • Chan-Zuckerberg Initiative
LATEST VERSION PUBLISHED 28 Oct 2020
https://doi.org/10.12688/f1000research.26707.2
Research Article metrics
Revised
The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days
[version 2; peer review: 2 approved]
Peer Reviewers Margaret McCartney; Atle Fretheim
  • Funders
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Laura and John Arnold Foundation
LATEST VERSION PUBLISHED 26 Oct 2020
https://doi.org/10.12688/f1000research.24651.2
Research Article metrics
Revised
In vitro efficacy of a copper iodine complex PPE disinfectant for SARS-CoV-2 inactivation
[version 2; peer review: 2 approved]
Peer Reviewers Ilya Frolov; Paul Dabisch
  • Funder
  • Clyra Medical Technologies, Inc.
LATEST VERSION PUBLISHED 07 Oct 2020
https://doi.org/10.12688/f1000research.26731.1
Research Article metrics
Bioinformatic study to discover natural molecules with activity against COVID-19
[version 1; peer review: 2 approved]
Peer Reviewers Pritha Ghosh; Maria Florencia Pollo-Cattaneo
  • Funder
  • Universidad Distrital Francisco Jose de Caldas
PUBLISHED 06 Oct 2020
https://doi.org/10.12688/f1000research.25979.2
Review metrics
Revised
Immunopathology of galectin-3: an increasingly promising target in COVID-19
[version 2; peer review: 2 approved]
Peer Reviewers Talia H Swartz; Thirunavukkarasu Velusamy
LATEST VERSION PUBLISHED 28 Sep 2020
https://doi.org/10.12688/f1000research.26359.1
Research Article metrics
Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19
[version 1; peer review: 2 approved]
Peer Reviewers Harish Holla; P Hemachandra Reddy
  • Funders
  • Science and Engineering Research Board
  • Indian Council of Medical Research
  • Manipal Academy of Higher Education
PUBLISHED 23 Sep 2020
https://doi.org/10.12688/f1000research.25076.1
Research Article metrics
Molecular docking analysis of selected phytochemicals on two SARS-CoV-2 targets
[version 1; peer review: 1 approved, 1 approved with reservations]
Peer Reviewers Yogendra Nayak; Adel S Girgis
  • Funders
  • World Bank Group
  • African Union
PUBLISHED 21 Sep 2020
https://doi.org/10.12688/f1000research.23107.2
Research Article metrics
Revised
Tracking and forecasting milepost moments of the epidemic in the early-outbreak: framework and applications to the COVID-19
[version 2; peer review: 2 approved]
Peer Reviewers Rosanna Verde; Paula Brito
  • Funder
  • National Natural Science Foundation of China
LATEST VERSION PUBLISHED 18 Sep 2020
121-140 of 176 ARTICLES
Gateway Areas
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.